Skip to main content
Top
Published in: Medical Oncology 4/2014

01-04-2014 | Original Paper

Genetic polymorphisms of XRCC1 gene and susceptibility to hepatocellular carcinoma in Chinese population

Authors: Tao Jiang, Longjiu Cui, Libo Chen, Zhongxiang Liu, Hui Ren

Published in: Medical Oncology | Issue 4/2014

Login to get access

Abstract

Hepatocellular carcinoma (HCC) is a common cancer in the worldwide. Accumulated evidences indicate that genetic polymorphisms of human X-ray repair complementing group 1 gene (XRCC1) are associated with the susceptibility to HCC. This study aims to investigate the potential association between XRCC1 c.482C>T and c.1178G>A genetic polymorphisms and the susceptibility to HCC. A total of 1,069 Chinese Han subjects consisting of 530 HCC patients and 539 cancer-free controls were recruited in this case–control study. The created restriction site-polymerase chain reaction and directly DNA sequencing methods were utilized to analyze the genotyping of XRCC1 genetic polymorphisms. Our data suggested that the XRCC1 c.482C>T and c.1178G>A genetic polymorphisms were statistically associated with the increased risks of HCC [for c.482C>T, TT vs. CC: OR 2.05, 95 % CI 1.26–3.32, P = 0.003; T vs. C: OR 1.26, 95 % CI 1.04–1.51, P = 0.017; for c.1178G>A, AA vs. GG: OR 2.15, 95 % CI 1.26–3.67, P = 0.004; A vs. G: OR 1.33, 95 % CI 1.10–1.61, P = 0.004]. The allele-T and genotype-TT of c.482C>T and allele-A and genotype-AA of c.1178G>A genetic polymorphisms may enhance the susceptibility to HCC. Our findings indicate that the studied XRCC1 genetic polymorphisms may influence the risk of HCC in Chinese populations and might be used as molecular markers for assessing the risk of HCC.
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef
3.
4.
go back to reference Yu L, Sun L, Jiang YF, Lu BL, Sun DR, Zhu LY. Interactions between CYP1A1 polymorphisms and cigarette smoking are associated with the risk of hepatocellular carcinoma: evidence from epidemiological studies. Mol Biol Rep. 2012;39:6641–6.PubMedCrossRef Yu L, Sun L, Jiang YF, Lu BL, Sun DR, Zhu LY. Interactions between CYP1A1 polymorphisms and cigarette smoking are associated with the risk of hepatocellular carcinoma: evidence from epidemiological studies. Mol Biol Rep. 2012;39:6641–6.PubMedCrossRef
6.
go back to reference Yuen MF, Hou JL, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009;24:346–53.PubMedCrossRef Yuen MF, Hou JL, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009;24:346–53.PubMedCrossRef
8.
go back to reference Schutte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma—epidemiological trends and risk factors. Dig Dis. 2009;27:80–92.PubMed Schutte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma—epidemiological trends and risk factors. Dig Dis. 2009;27:80–92.PubMed
9.
go back to reference Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–87.PubMedCrossRef Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–87.PubMedCrossRef
10.
go back to reference El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.PubMedCrossRef El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.PubMedCrossRef
11.
go back to reference Amarapurkar DN, Patel ND, Kamani PM. Impact of diabetes mellitus on outcome of HCC. Ann Hepatol. 2008;7:148–51.PubMed Amarapurkar DN, Patel ND, Kamani PM. Impact of diabetes mellitus on outcome of HCC. Ann Hepatol. 2008;7:148–51.PubMed
12.
go back to reference Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol. 2005;42:218–24.PubMedCrossRef Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol. 2005;42:218–24.PubMedCrossRef
13.
go back to reference Rossit AR, Cabral IR, Hackel C, da Silva R, Froes ND, Abdel-Rahman SZ. Polymorphisms in the DNA repair gene XRCC1 and susceptibility to alcoholic liver cirrhosis in older Southeastern Brazilians. Cancer Lett. 2002;180:173–82.PubMedCrossRef Rossit AR, Cabral IR, Hackel C, da Silva R, Froes ND, Abdel-Rahman SZ. Polymorphisms in the DNA repair gene XRCC1 and susceptibility to alcoholic liver cirrhosis in older Southeastern Brazilians. Cancer Lett. 2002;180:173–82.PubMedCrossRef
14.
go back to reference Yu MW, Yang SY, Pan IJ, Lin CL, Liu CJ, Liaw YF, Lin SM, Chen PJ, Lee SD, Chen CJ. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst. 2003;95:1485–8.PubMedCrossRef Yu MW, Yang SY, Pan IJ, Lin CL, Liu CJ, Liaw YF, Lin SM, Chen PJ, Lee SD, Chen CJ. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst. 2003;95:1485–8.PubMedCrossRef
15.
go back to reference Kiran M, Chawla YK, Jain M, Kaur J. Haplotypes of microsomal epoxide hydrolase and X-ray cross-complementing group 1 genes in Indian hepatocellular carcinoma patients. DNA Cell Biol. 2009;28:573–7.PubMedCrossRef Kiran M, Chawla YK, Jain M, Kaur J. Haplotypes of microsomal epoxide hydrolase and X-ray cross-complementing group 1 genes in Indian hepatocellular carcinoma patients. DNA Cell Biol. 2009;28:573–7.PubMedCrossRef
16.
go back to reference Kiran M, Saxena R, Chawla YK, Kaur J. Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol Cell Biochem. 2009;327:7–13.PubMedCrossRef Kiran M, Saxena R, Chawla YK, Kaur J. Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol Cell Biochem. 2009;327:7–13.PubMedCrossRef
17.
go back to reference Pan HZ, Liang J, Yu Z, Lun LM, Li H, Wang Q. Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population. Asian Pac J Cancer Prev. 2011;12:2947–50.PubMed Pan HZ, Liang J, Yu Z, Lun LM, Li H, Wang Q. Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population. Asian Pac J Cancer Prev. 2011;12:2947–50.PubMed
18.
go back to reference Li QW, Lu CR, Ye M, Xiao WH, Liang J. Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. Asian Pac J Cancer Prev. 2012;13:191–4.PubMedCrossRef Li QW, Lu CR, Ye M, Xiao WH, Liang J. Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. Asian Pac J Cancer Prev. 2012;13:191–4.PubMedCrossRef
19.
go back to reference Han X, Xing Q, Li Y, Sun J, Ji H, Huazheng P, Jun L. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. Hepatogastroenterology. 2012;59:2285–9.PubMed Han X, Xing Q, Li Y, Sun J, Ji H, Huazheng P, Jun L. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. Hepatogastroenterology. 2012;59:2285–9.PubMed
20.
go back to reference Long XD, Ma Y, Huang HD, Yao JG, de Qu Y, Lu YL. Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among Guangxi population, China. Mol Carcinog. 2008;47:295–300.PubMedCrossRef Long XD, Ma Y, Huang HD, Yao JG, de Qu Y, Lu YL. Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among Guangxi population, China. Mol Carcinog. 2008;47:295–300.PubMedCrossRef
21.
go back to reference Liu F, Li B, Wei Y, Yan L, Wen T, Zhao J, Xu M. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis. Liver Int. 2011;31:802–9.PubMedCrossRef Liu F, Li B, Wei Y, Yan L, Wen T, Zhao J, Xu M. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis. Liver Int. 2011;31:802–9.PubMedCrossRef
22.
go back to reference Borentain P, Gerolami V, Ananian P, Garcia S, Noundou A, Botta-Fridlund D, Le Treut YP, Berge-Lefranc JL, Gerolami R. DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients. Eur J Cancer. 2007;43:2479–86.PubMedCrossRef Borentain P, Gerolami V, Ananian P, Garcia S, Noundou A, Botta-Fridlund D, Le Treut YP, Berge-Lefranc JL, Gerolami R. DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients. Eur J Cancer. 2007;43:2479–86.PubMedCrossRef
23.
go back to reference Long XD, Ma Y, Wei YP, Deng ZL. The polymorphisms of GSTM1, GSTT1, HYL1* 2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res. 2006;36:48–55.PubMedCrossRef Long XD, Ma Y, Wei YP, Deng ZL. The polymorphisms of GSTM1, GSTT1, HYL1* 2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res. 2006;36:48–55.PubMedCrossRef
24.
go back to reference Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM, Lee SD, Chen PJ, Chen CJ, Yu MW. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol. 2005;34:1310–8.PubMedCrossRef Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM, Lee SD, Chen PJ, Chen CJ, Yu MW. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol. 2005;34:1310–8.PubMedCrossRef
25.
go back to reference Kirk GD, Turner PC, Gong Y, Lesi OA, Mendy M, Goedert JJ, Hall AJ, Whittle H, Hainaut P, Montesano R, Wild CP. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev. 2005;14:373–9.PubMedCrossRef Kirk GD, Turner PC, Gong Y, Lesi OA, Mendy M, Goedert JJ, Hall AJ, Whittle H, Hainaut P, Montesano R, Wild CP. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev. 2005;14:373–9.PubMedCrossRef
26.
go back to reference Li J, Li Z, Feng L, Guo W, Zhang S. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis. Tumour Biol. 2013;34:261–9.PubMedCrossRef Li J, Li Z, Feng L, Guo W, Zhang S. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis. Tumour Biol. 2013;34:261–9.PubMedCrossRef
27.
go back to reference Guo LY, Jin XP, Niu W, Li XF, Liu BH, Wang YL. Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk. Asian Pac J Cancer Prev. 2012;13:4423–6.PubMedCrossRef Guo LY, Jin XP, Niu W, Li XF, Liu BH, Wang YL. Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk. Asian Pac J Cancer Prev. 2012;13:4423–6.PubMedCrossRef
28.
go back to reference Duan WH, Zhu ZY, Liu JG, Dong MS, Chen JZ, Liu QD, Xie Y, Sun TY, Gao ZF, Zhou NX. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Chinese Han population: a meta-analysis. Asian Pac J Cancer Prev. 2012;13:3601–4.PubMedCrossRef Duan WH, Zhu ZY, Liu JG, Dong MS, Chen JZ, Liu QD, Xie Y, Sun TY, Gao ZF, Zhou NX. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Chinese Han population: a meta-analysis. Asian Pac J Cancer Prev. 2012;13:3601–4.PubMedCrossRef
29.
go back to reference Bi J, Zhong C, Li K, Chu H, Wang B. Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population. Biomed Res Int. 2013;2013:138785.PubMedCentralPubMed Bi J, Zhong C, Li K, Chu H, Wang B. Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population. Biomed Res Int. 2013;2013:138785.PubMedCentralPubMed
30.
go back to reference Bose S, Tripathi DM, Sukriti Sakhuja P, Kazim SN, Sarin SK. Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer. Gene. 2013;519:231–7.PubMedCrossRef Bose S, Tripathi DM, Sukriti Sakhuja P, Kazim SN, Sarin SK. Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer. Gene. 2013;519:231–7.PubMedCrossRef
31.
go back to reference Deng X, Liang J, Jiang M, Zhou X, Liu H. Association between the C.1161G>A and C.1779C>G genetic variants of XRCC1 gene and hepatocellular carcinoma risk in Chinese population. Int J Biol Sci. 2013;9:289–94.PubMedCentralPubMedCrossRef Deng X, Liang J, Jiang M, Zhou X, Liu H. Association between the C.1161G>A and C.1779C>G genetic variants of XRCC1 gene and hepatocellular carcinoma risk in Chinese population. Int J Biol Sci. 2013;9:289–94.PubMedCentralPubMedCrossRef
32.
go back to reference Li LP, Wu W, Li XH, Song SS. The XRCC1 Arg280His gene polymorphism and hepatocellular carcinoma risk: a meta-analysis. Asian Pac J Cancer Prev. 2013;14:2033–6.PubMedCrossRef Li LP, Wu W, Li XH, Song SS. The XRCC1 Arg280His gene polymorphism and hepatocellular carcinoma risk: a meta-analysis. Asian Pac J Cancer Prev. 2013;14:2033–6.PubMedCrossRef
33.
go back to reference Pan Y, Zhao L, Chen XM, Gu Y, Shen JG, Liu LM. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis. Asian Pac J Cancer Prev. 2013;14:5761–7.PubMedCrossRef Pan Y, Zhao L, Chen XM, Gu Y, Shen JG, Liu LM. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis. Asian Pac J Cancer Prev. 2013;14:5761–7.PubMedCrossRef
34.
go back to reference Wu D, Jiang H, Gu Q, Zhang D, Li Z. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population. Tumour Biol. 2013;34:3265–9.PubMedCrossRef Wu D, Jiang H, Gu Q, Zhang D, Li Z. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population. Tumour Biol. 2013;34:3265–9.PubMedCrossRef
35.
go back to reference Yue AM, Xie ZB, Guo SP, Wei QD, Yang XW. Implication of polymorphisms in DNA repair genes in prognosis of hepatocellular carcinoma. Asian Pac J Cancer Prev. 2013;14:355–8.PubMedCrossRef Yue AM, Xie ZB, Guo SP, Wei QD, Yang XW. Implication of polymorphisms in DNA repair genes in prognosis of hepatocellular carcinoma. Asian Pac J Cancer Prev. 2013;14:355–8.PubMedCrossRef
36.
go back to reference Zeng XY, Huang JM, Xu JW, Xu Y, Yu HP, Ji L, Qiu XQ. Meta-analysis demonstrates lack of a relationship between XRCC1-399 gene polymorphisms and susceptibility to hepatocellular carcinoma. Genet Mol Res. 2013;12:1916–23.PubMedCrossRef Zeng XY, Huang JM, Xu JW, Xu Y, Yu HP, Ji L, Qiu XQ. Meta-analysis demonstrates lack of a relationship between XRCC1-399 gene polymorphisms and susceptibility to hepatocellular carcinoma. Genet Mol Res. 2013;12:1916–23.PubMedCrossRef
37.
go back to reference Tudek B. Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med. 2007;28:258–75.PubMedCrossRef Tudek B. Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med. 2007;28:258–75.PubMedCrossRef
38.
go back to reference Mutamba JT, Svilar D, Prasongtanakij S, Wang XH, Lin YC, Dedon PC, Sobol RW, Engelward BP. XRCC1 and base excision repair balance in response to nitric oxide. DNA Repair (Amst). 2011;10:1282–93.CrossRef Mutamba JT, Svilar D, Prasongtanakij S, Wang XH, Lin YC, Dedon PC, Sobol RW, Engelward BP. XRCC1 and base excision repair balance in response to nitric oxide. DNA Repair (Amst). 2011;10:1282–93.CrossRef
39.
go back to reference Zhang L, Wang Y, Qiu Z, Luo J, Zhou Z, Shu W. The XRCC1 Arg194Trp polymorphism is not a risk factor for glioma: a meta-analysis involving 1,440 cases and 2,562 controls. Exp Ther Med. 2012;4:1057–62.PubMedCentralPubMed Zhang L, Wang Y, Qiu Z, Luo J, Zhou Z, Shu W. The XRCC1 Arg194Trp polymorphism is not a risk factor for glioma: a meta-analysis involving 1,440 cases and 2,562 controls. Exp Ther Med. 2012;4:1057–62.PubMedCentralPubMed
40.
go back to reference Haliassos A, Chomel JC, Tesson L, Baudis M, Kruh J, Kaplan JC, Kitzis A. Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res. 1989;17:3606.PubMedCentralPubMedCrossRef Haliassos A, Chomel JC, Tesson L, Baudis M, Kruh J, Kaplan JC, Kitzis A. Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res. 1989;17:3606.PubMedCentralPubMedCrossRef
41.
go back to reference Yuan ZR, Li J, Li JY, Gao X, Xu SZ. SNPs identification and its correlation analysis with milk somatic cell score in bovine MBL1 gene. Mol Biol Rep. 2013;40:7–12.PubMedCrossRef Yuan ZR, Li J, Li JY, Gao X, Xu SZ. SNPs identification and its correlation analysis with milk somatic cell score in bovine MBL1 gene. Mol Biol Rep. 2013;40:7–12.PubMedCrossRef
42.
go back to reference Yuan ZR, Li JY, Li J, Zhang LP, Gao X, Gao HJ, Xu SZ. Investigation on BRCA1 SNPs and its effects on mastitis in Chinese commercial cattle. Gene. 2012;505:190–4.PubMedCrossRef Yuan ZR, Li JY, Li J, Zhang LP, Gao X, Gao HJ, Xu SZ. Investigation on BRCA1 SNPs and its effects on mastitis in Chinese commercial cattle. Gene. 2012;505:190–4.PubMedCrossRef
43.
go back to reference Yuan ZR, Li JY, Li J, Gao X, Xu SZ. Effects of DGAT1 gene on meat and carcass fatness quality in Chinese commercial cattle. Mol Biol Rep. 2013;40:1947–54.PubMedCrossRef Yuan ZR, Li JY, Li J, Gao X, Xu SZ. Effects of DGAT1 gene on meat and carcass fatness quality in Chinese commercial cattle. Mol Biol Rep. 2013;40:1947–54.PubMedCrossRef
44.
go back to reference Zhao CJ, Li N, Deng XM. The establishment of method for identifying SNP genotype by CRS-PCR. Yi Chuan. 2003;25:327–9.PubMed Zhao CJ, Li N, Deng XM. The establishment of method for identifying SNP genotype by CRS-PCR. Yi Chuan. 2003;25:327–9.PubMed
Metadata
Title
Genetic polymorphisms of XRCC1 gene and susceptibility to hepatocellular carcinoma in Chinese population
Authors
Tao Jiang
Longjiu Cui
Libo Chen
Zhongxiang Liu
Hui Ren
Publication date
01-04-2014
Publisher
Springer US
Published in
Medical Oncology / Issue 4/2014
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0887-6

Other articles of this Issue 4/2014

Medical Oncology 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.